Delivery Order SPE2DR25D2005-SPE2DR26FE6S4
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Nucynta ER 200 mg tablets (60-count units) valued at $4,050.39. This firm fixed-price contract, with an ultimate completion date of August 6, 2025, represents a non-set-aside competitive award to support federal pharmaceutical procurement needs. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,941.77 to AmerisourceBergen Drug Corp for the supply of Nucynta ER 200 mg tablets (60-count units) on August 29, 2025, with a completion date of September 2, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Nucynta ER 100 mg tablets (60-count units) with a contract ceiling value of $12,962.44. This competitively awarded, firm fixed-price delivery order is set to conclude on October 30, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Nucynta ER 100 mg tablets (60-count units) valued at $2,650.80. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is set to complete by October 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 16, 2025, for the supply of Nucynta ER 50 mg tablets (60-count packages) under a firm fixed-price contract valued at $3,724.40. This competitively awarded, non-set-aside delivery order is scheduled for completion by October 17, 2025, with performance taking place at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of the vendor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Nucynta ER 150 mg tablets (60-count units) with a ceiling value of $3,263.99. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is set to complete by August 5, 2025, and performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Nucynta ER 50 mg tablets (60-count units) with a contract ceiling value of $1,077.64. The award, issued on May 30, 2025, with an ultimate completion date of June 2, 2025, utilizes firm fixed pricing under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 26, 2025, for the supply of Nucynta ER 50 mg tablets (60-count units) with a contract value of $1,990.55. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through competitive procurement. The contract is set for ultimate completion by September 29, 2025, and will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Nucynta ER 200 mg tablets (60-count units) under a firm fixed-price contract with a ceiling value of $2,761.93. This non-set-aside delivery order represents a competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 22, 2025. The order falls under AmerisourceBergen's...
- This delivery order, awarded on October 20, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, covers the supply of Nucynta ER 100 mg tablets (60-count units) with a ceiling value of $1,425.14. The contract operates under a firm fixed-price arrangement with an ultimate completion date of October 21, 2025, and was competitively awarded without any set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FE6S4Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Nucynta ER 100 mg tablets (60-count units) with a ceiling value of $1,425.14. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract is set to be completed by November 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military healthcare systems and other government entities. The parent IDC serves as a global pharmaceutical support vehicle enabling the delivery of brand-name and generic drugs, vaccines, and specialized medical commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare customers worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 11/13/25 |